Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy and safety of co-administration of Abilify(aripiprazole) with
Depakote(divalproate) in the acute phase of 6-week treatment of acute mania in patients with
bipolar disorder.